Theravance Biopharma Inc (TBPH)
Cost of Revenue
$1.44M
Quarterly · Period ending: · USD
TBPH Cost of Revenue
Latest reported$1.44Mperiod ending
Latest reported$1.44Mperiod ending
TBPH Quarterly Cost of Revenue ($0.00 → $1.44M)
Quarterly cost of revenue
High-resolution chart · PNG
TBPH cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 1,443,000 | |
| 0 | |
| 1,506,000 | |
| 8,112,000 | |
| 10,490,000 | |
| 11,452,000 | |
| 9,453,000 | |
| 9,268,000 | |
| 9,954,000 | |
| 8,968,000 | |
| 8,313,000 | |
| 1,339,000 | |
| 9,425,000 | |
| 14,572,000 | |
| 15,348,000 | |
| 9,867,000 | |
| 14,924,000 | |
| 23,253,000 | |
| 31,226,000 | |
| 43,739,000 | |
| 51,093,000 | |
| 67,599,000 | |
| 65,165,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 52,006,000 | |
| 46,399,000 | |
| 53,818,000 | |
| 632,000 | |
| 705,000 | |
| 47,173,000 | |
| 826,000 | |
| 3,116,000 | |
| 985,000 | |
| 1,364,000 | |
| 565,000 | |
| 1,146,000 | |
| 332,000 | |
| 638,000 | |
| 778,000 | |
| 3,201,000 | |
| 581,000 | |
| 505,000 | |
| 371,000 | |
| 3,222,000 | |
| 369,000 | |
| 279,000 | |
| 188,000 | |
| 32,470,000 | |
| 32,301,000 | |
| 30,400,000 | |
| 25,408,000 | |
| 100,803,000 | |
| 0 |